ESR2 and breast carcinoma: In fact, a previous study reported that instead of targeting ER, Dip G targets the CHIP E3 ubiquitin ligase shares by ERα and ERβ, and increases ERβ protein stability, while decreasing ERα protein levels in breast cancer cells24.